Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine
about
sameAs
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involvedThe opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case reportGetting the balance right: Established and emerging therapies for major depressive disordersAntidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structuresIncreased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysisA comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS studyThe pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citaloprammeso-Transdiene analogs inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine releaseRationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram vEndogenous serotonin acts on 5-HT2C-like receptors in key vocal areas of the brain stem to initiate vocalizations in Xenopus laevis.A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Effects of escitalopram on attentional bias to cocaine-related stimuli and inhibitory control in cocaine-dependent subjects.Tolerability and safety of fluvoxamine and other antidepressants.Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteersFluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.Escitalopram Versus Citalopram and Sertraline: A Double-Blind Controlled, Multi-centric Trial in Indian Patients with Unipolar Major Depression.Novel N-1,2-dihydroxypropyl analogs of lobelane inhibit vesicular monoamine transporter-2 function and methamphetamine-evoked dopamine release.Identifying mechanism-of-action targets for drugs and probes.Stereochemistry in Drug ActionDuloxetine for the management of fibromyalgia syndrome.Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysisVortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.X-ray structures and mechanism of the human serotonin transporter.Stereoisomers in Psychiatry: The Case of Escitalopram.Bupropion: pharmacology and therapeutic applications.Escitalopram.Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptorsThe interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.Escitalopram: A New SSRI for the Treatment of Depression in Primary Care.Monoamine reuptake inhibitors in Parkinson's disease.Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.A Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder.PharmGKB summary: citalopram pharmacokinetics pathway.Escitalopram in the treatment of generalized anxiety disorder.The solute carrier 6 family of transportersManaging depressive and anxiety disorders with escitalopram.Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertensionPharmacological properties of the active metabolites of the antidepressants desipramine and citalopram.Antidepressant-induced akathisia-related homicides associated with diminishing mutations in metabolizing genes of the CYP450 family.
P2860
Q21129279-2A1C7195-0A60-4D17-8311-D76CE8D9635CQ21203919-187BEBDB-90FD-4B17-A1BC-DB7C0B348EE8Q24610225-83CAEC0E-123D-4565-9F07-EF68C8E2D875Q24655640-ACCF0449-FF45-4FC0-A791-FAECF6601718Q28196269-0B4C0453-01B8-43CD-97DC-D8B436BA64FDQ28249891-8394AEA4-AB23-4007-9A80-BEDE4F98B98BQ28258698-78F3734E-410E-4627-996B-8C636A4E2391Q30498938-5A40EF3F-36CE-443A-ABD9-C85234DFF8EDQ33492562-B4D74957-7881-4EA5-8ADD-2173F0B1B1A1Q33656906-496DC728-228D-492E-AA9B-8B34818110FAQ33718185-5AC8F2BC-FF8F-4785-ABAC-B92BA84ACB3CQ33753053-FBAC3321-F5FB-4EE4-A689-5B4E4BFC658CQ33995120-701FDF65-72DB-4AA2-B934-A6D0FF40198BQ34019331-B0353A8C-5F8C-435E-8306-2EFF55E479B8Q34079552-DB4CC82E-4E7C-41A1-ABD9-2B2A02A136FEQ34180357-3E8DEE39-FDCC-4917-AB79-767D82E2B31CQ34202539-CDD3FBA9-4ACE-4B08-80C8-16895D4D7345Q34282670-ABA60E04-DA80-45C8-B923-B8826EDED9D2Q34322267-8CAB5E08-6230-4062-9533-CC70ED964B8FQ34418217-8444EBC7-C7C1-4E4A-A7F6-90CEEA8529E1Q34480541-A4D600AF-1414-43FB-B498-D1221A86D91AQ34505291-EFADE697-1DAB-4E60-A837-8FE64DB7AC91Q34521033-89A60C41-60E1-4D4F-98C4-26D853AF1917Q34546245-A82A1B52-DA3A-4CBC-A99D-2AF6788702D7Q34569990-EEC6A63B-0052-47C1-BEB7-B952958FB425Q34974884-C3B2F841-3EFA-4ED3-8440-8EA6607A522CQ35047176-3176E950-E445-477E-8CD5-FE91EF6E1B3BQ35137131-4C08F6F4-4190-49A1-A378-48E00384387AQ35160849-998A7832-8F85-4B14-B9DB-D8617DE5EA09Q35165280-B2BE0BE1-59AA-41B5-917B-333FFE44B868Q35448551-E7D179BC-AC3F-4451-831D-13BB38C1E383Q35612732-95F890B6-2853-4EC8-9AAE-010146FC6A11Q35918242-37DFE39A-4C74-4691-84D7-DEBCD27ABD58Q35952370-8939B3A3-244D-41B5-81D7-9A744D0D7856Q36198579-62418775-B8FB-4163-8E15-274CE875CD93Q36346899-D28ADDFB-E635-4D02-9474-985F916B5FD8Q36407369-E30D0CEF-EF21-47E1-98AB-053762227960Q36411210-47EDDB49-D880-44C9-AA16-C67F4C9E60E5Q36439975-BBA7C9A5-090C-420F-9722-5C85689825A6Q36441503-A0DB084D-A2CF-4659-B963-06138773105E
P2860
Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@ast
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@en
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@nl
type
label
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@ast
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@en
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@nl
prefLabel
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@ast
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@en
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@nl
P2093
P3181
P1476
Second-generation SSRIs: human ...... escitalopram and R-fluoxetine
@en
P2093
C B Nemeroff
D L Knight
P304
P3181
P356
10.1016/S0006-3223(01)01145-3
P407
P577
2001-09-01T00:00:00Z